These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 15037412

  • 1. Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome.
    Belli SH, Graffigna MN, Oneto A, Otero P, Schurman L, Levalle OA.
    Fertil Steril; 2004 Mar; 81(3):624-9. PubMed ID: 15037412
    [Abstract] [Full Text] [Related]

  • 2. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 3. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA, Shin SY, Yoon BK, Choi D.
    Gynecol Endocrinol; 2007 Dec; 23(8):461-7. PubMed ID: 17852414
    [Abstract] [Full Text] [Related]

  • 4. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
    Pawelczyk L, Spaczynski RZ, Banaszewska B, Duleba AJ.
    Eur J Obstet Gynecol Reprod Biol; 2004 Apr 15; 113(2):209-13. PubMed ID: 15063962
    [Abstract] [Full Text] [Related]

  • 5. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.
    Fertil Steril; 2004 Oct 15; 82(4):893-902. PubMed ID: 15482765
    [Abstract] [Full Text] [Related]

  • 6. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.
    Ortega-González C, Cardoza L, Coutiño B, Hidalgo R, Arteaga-Troncoso G, Parra A.
    J Endocrinol; 2005 Jan 15; 184(1):233-9. PubMed ID: 15642799
    [Abstract] [Full Text] [Related]

  • 7. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr 15; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 8. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M, Aydemir M, Tuzcu A.
    Fertil Steril; 2007 Jun 15; 87(6):1363-8. PubMed ID: 17362944
    [Abstract] [Full Text] [Related]

  • 9. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M.
    Gynecol Endocrinol; 2005 Sep 15; 21(3):154-60. PubMed ID: 16335907
    [Abstract] [Full Text] [Related]

  • 10. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS, Rouzi AA.
    Fertil Steril; 2005 Jun 15; 83(6):1708-16. PubMed ID: 15950640
    [Abstract] [Full Text] [Related]

  • 11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.
    Neuro Endocrinol Lett; 2007 Dec 15; 28(6):807-10. PubMed ID: 18063948
    [Abstract] [Full Text] [Related]

  • 12. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
    Panidis D, Rousso D, Koliakos G, Kourtis A, Katsikis I, Farmakiotis D, Votsi E, Diamanti-Kandarakis E.
    Fertil Steril; 2006 Jun 15; 85(6):1778-83. PubMed ID: 16650418
    [Abstract] [Full Text] [Related]

  • 13. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y, Mao WW, Chen YJ, Li MZ, Qiao J, Wang LN.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 15; 42(11):756-60. PubMed ID: 18307903
    [Abstract] [Full Text] [Related]

  • 14. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

  • 15. [Effects of metformin on the plasminogen activator system, endocrine, metabolic profiles in patients with polycystic ovary syndrome and clomiphene resistant cases].
    Song J, Shen H, Li J, Huang Z, Zhang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb 01; 37(2):86-9. PubMed ID: 11953071
    [Abstract] [Full Text] [Related]

  • 16. Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study.
    Rautio K, Tapanainen JS, Ruokonen A, Morin-Papunen LC.
    Hum Reprod; 2006 Jun 01; 21(6):1400-7. PubMed ID: 16501039
    [Abstract] [Full Text] [Related]

  • 17. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
    Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM.
    Hum Reprod; 2006 Jan 01; 21(1):109-20. PubMed ID: 16155076
    [Abstract] [Full Text] [Related]

  • 18. Abnormal response of insulin to glucose loading and assessment of insulin resistance in non-obese patients with polycystic ovary syndrome.
    Takeuchi T, Tsutsumi O, Taketani Y.
    Gynecol Endocrinol; 2008 Jul 01; 24(7):385-91. PubMed ID: 18645711
    [Abstract] [Full Text] [Related]

  • 19. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.
    Carmina E, Lobo RA.
    Fertil Steril; 2004 Sep 01; 82(3):661-5. PubMed ID: 15374711
    [Abstract] [Full Text] [Related]

  • 20. The effects of oral contraceptives including low-dose estrogen and drospirenone on the concentration of leptin and ghrelin in polycystic ovary syndrome.
    Sağsöz N, Orbak Z, Noyan V, Yücel A, Uçar B, Yildiz L.
    Fertil Steril; 2009 Aug 01; 92(2):660-6. PubMed ID: 18973889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.